Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up study of oral macitentan in pulmonary hypertension
CTR20250682Phase 3Active
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan in pulmonary hypertension (PH), sponsored by Actelion Pharmaceuticals Ltd. Started Apr 2025; status: active.
02
Drugs
macitentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on CTR20250682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250682.